Biomaterials Forum Issues
Publications
2024 Q4 Biomaterials Forum is Available Now!
This issue includes a highlight of the celebration of the 50-year legacy of the Society at the 2025 Annual Meeting, as well as details of the recent US FDA approval of two new medical therapies, and the US DOJ's efforts to block UnitedHealth Group's proposed acquisition of Amedisys. Read more inside!
Third Quarter 2009
Second Quarter 2009
First Quarter 2009
Fourth Quarter 2008
Third Quarter 2008
Second Quarter 2008
First Quarter 2008
Fourth Quarter 2007
Third Quarter 2007
Second Quarter 2007
First Quarter 2007
Fourth Quarter 2006
Third Quarter 2006
Second Quarter 2006
First Quarter 2006
Fourth Quarter 2005
Third Quarter 2005
Second Quarter 2005
First Quarter 2005
Fourth Quarter 2004